Review of Current Authorship Guidelines and the Controversy Regarding Publication of Clinical Trial Data
Biotechnology Annual Review 2003; 9: 303-313
Showing items related by title, author, creator and subject.
The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences: Part 2: A Qualitative, Systematic Review of the Literature on Possible Influences on Authorship, Access to Trial Data, and Trial Registration and Publication Schott, Gisela; Pachl, Henry; Limbach, Ulrich; Gundert-Remy, Ursula; Lieb, Klaus; Ludwig, Wolf-Dieter (2010-04)In recent years, a number of studies have shown that clinical drug trials financed by pharmaceutical companies yield favorable results for company products more often than independent trials do. Moreover, pharmaceutical ...
What's Missing From Current Clinical Trial Guidelines? a Framework for Integrating Science, Ethics, and the Community Context Sutherland, Heather J.; Meslin, Eric M.; Till, James E. (1994)Researchers have been charged with the task of undertaking methodologically rigorous and ethically acceptable clinical trials with human subjects. Guidance to produce proposals of exemplary quality is offered in the many ...
What's Missing From Current Clinical Trial Guidelines? A Framework for Integrating Science, Ethics, and the Community Context Sutherland, Heather J.; Meslin, Eric M.; Till, James E. (1994-12)